Tuesday 27 December 2022

Top 5 Most-Popular Psoriasis Content of 2022

From ajmc.com

This year’s most-popular content on psoriasis include research regarding disparities and socioeconomic factors that impact psoriasis treatment and an interview on shared decision making.

The top 5 most-popular psoriasis content this year includes research into geographical differences in mortality, risk factors associated with psoriasis, and the importance of shared decision-making for better managing of this skin condition.

5. Dr Patrick Burnett on Shared Decision-Making for Moderate to Severe Psoriasis

Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discussed key clinical recommendations for patients with moderate to severe psoriasis with uncontrolled disease, stressing the importance of having a conversation with patients about their end-goal in treatment, focusing bettering their quality of life.

Burnett also discussed the importance of shared decision-making in treating patients with moderate to severe psoriasis.

Watch the interview.

4. Pulling Apart Methods of Diagnosing Axial Psoriatic Arthritis, Back Pain

Despite the high prevalence of axial disease among patients with psoriatic arthritis, disagreement on definitions caused difficulty in diagnosing axial spondylarthritis and back pain. Furthermore, the researchers of this study found notable differences when comparing psoriatic arthritis with ankylosing spondylitis in terms of intensity of back pain and mobility.

Read the full article.

3. Study Highlights Wide Variation in Mortality of Spondyloarthritis, IBD Across the Globe

Large variations in mortality rates for spondylarthritis and inflammatory bowel disease were found geographically. These variations highlight different disparities and socioeconomic factors that may have affected mortality rates across different regions.

Read the full article.

2. TNF Inhibitors Linked to Higher Risk of Psoriasis in Patients With IBD, RA

Researchers underscored the risk of new-onset psoriasis due to tumour necrosis factor-a (TNF) inhibitor. Patients with immune-mediated inflammatory diseases had a 2-fold risk of new-onset psoriasis, according to the study.

Read the full article.

1. Study Finds Link Between Psoriasis, NAFLD Among US Adult Outpatients

One study found outpatients with psoriasis were at greater risk of developing non-alcoholic fatty liver disease (NAFLD) than those without the skin condition. These findings validated prior research on this subject matter, that had found psoriasis to be linked to several comorbid conditions, including cardiovascular diseases, diabetes, and NAFLD.

Read the full article.

https://www.ajmc.com/view/top-5-most-popular-psoriasis-content-of-2022 

No comments:

Post a Comment